Discontinuation of GLP-1RA Treatment Reinstates Binge-Like Eating and Drives Body Weight Past Pre-Treatment Levels in Mice
Abstract
We examined the impact of semaglutide treatment and discontinuation in a pre-clinical model for binge eating. Treatment reduced body weight and palatable food intake in mice with binge-like eating. Discontinuation reinstated binge-like eating and caused body weight to significantly exceed pre-treatment baseline, revealing specific binge-related risk when discontinuing GLP-1RAs.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chronic semaglutide treatment reveals stage-dependent changes to feeding behavior and metabolic adaptations in male mice
Harsh Shah, Julio E. Ayala·bioRxiv·Jul 24, 2025
- Physiology of the Weight Loss Plateau after Calorie Restriction, GLP-1 Receptor Agonism, and Bariatric Surgery
K. D. Hall·bioRxiv·Nov 5, 2023
- Examination of Onset Trajectories and Persistence of Binge-Like Eating Behavior in Mice after Intermittent Palatable Food Exposure
Britny A. Hildebrandt, Hayley Fisher, Susanne E. Ahmari·Behavioral NeurosciencePeer-reviewed·Feb 23, 2023
- Chronic semaglutide treatment enhances the incentive motivational value of a small food reward and associated cue in male and female rats
Stephen E. Chang, Christopher A. Turner, … Shelly B. Flagel·PsychopharmacologyPeer-reviewed·Mar 23, 2026
- Brainstem GLP-1 neurons modulate physiological satiation and drive sustained weight loss in obese mice
Wanqing Jiang, Cecilia Skoug, … Stefan Trapp·Molecular MetabolismPeer-reviewed·Mar 4, 2026
- Pavlovian conditioned approach with different reward magnitudes reveals opposing effects of acute and chronic semaglutide treatment
Stephanie S. Desrochers, Raymond Li, Shelly B. Flagel·bioRxiv·Sep 14, 2026